(Q48031324)

7 February 2018

title

Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides (English)

1 reference

7 February 2018

author name string

Kirkpatrick DL

1

1 reference

7 February 2018

Kuperus M

2

1 reference

7 February 2018

Dowdeswell M

3

1 reference

7 February 2018

Potier N

4

1 reference

7 February 2018

Donald LJ

5

1 reference

7 February 2018

Kunkel M

6

1 reference

7 February 2018

Berggren M

7

1 reference

7 February 2018

Angulo M

8

1 reference

7 February 2018

Powis G

9

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

7 February 2018

published in

Biochemical Pharmacology

1 reference

7 February 2018

volume

55

1 reference

7 February 2018

issue

7

1 reference

7 February 2018

page(s)

987-994

1 reference

7 February 2018

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900597-2

1 reference

Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73-->Ser mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900597-2

Reduced thioredoxin: a possible physiological cofactor for vitamin K epoxide reductase. Further support for an active site disulfide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900597-2

Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900597-2

The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900597-2

Expression and growth-promoting effect of adult T-cell leukemia-derived factor. A human thioredoxin homologue in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900597-2

Purification of human thioredoxin reductase: properties and characterization by absorption and circular dichroism spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900597-2

Glutathione reductase from human erythrocytes. Isolation of the enzyme and sequence analysis of the redox-active peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900597-2

Reflecting time-of-flight mass spectrometer with an electrospray ion source and orthogonal extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900597-2

Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900597-2

Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900597-2

10.1016/S0006-2952(97)00597-2

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018